Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former executive from the UK big pharma to advance its candidate amezosvatein.

The ongoing conflicts between Ukraine and Russia, as well as Israel and Palestine, have sent ripples across various ...

Our preclinical studies in animal models have demonstrated promising results in reducing obesity and fatty liver disease.

Can the continent walk the talk? **** The African Union has embarked on one of its most audacious health security missions: ...

Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that reduce costs and accelerate production.

Under the BioVersys and GSK collaboration agreement, GSK is evaluating the early bactericidal activity (EBA) of alpibectir-ethionamide (AlpE) in a pulmonary tuberculosis (TB) trial, in combination ...

Serving the pharmaceutical, bioscience and healthcare industry, IAG Cargo’s Constant Climate product is a cutting-edge cold chain solution designed ...

Company expects to have sufficient cash to fund planned operations beyond the FDA PDUFA goal date and anticipated fourth ...

Croda International Plc (Yorkshire, U.K.;   today announces the opening of a pioneering new lipids manufacturing facility in Lamar, ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...

If left unchecked, the power of PBMs and their complex relationships within the American healthcare system could lead to higher drug costs and diminished returns.